Antoni Wiedlocha funded by the EEA Poland-Norway grants
Antoni Wiedlocha
The proposal "Novel targeted therapy based on dual warhead conjugates against FGFR dependent cancers", with senior scientist Antoni Wiedlocha at Department of Molecular Cell Biology, Institute for Cancer Research, as Norwegian partner and professor Jacek Otlewski at the University of Wroclaw as Polish parther, has been awarded funding from the EEA Poland-Norway grants under the "Applied Research" programme.
Links:
From the National Centre for Research and Development in Poland:
Published in Level 2 journals, first or last author from Oslo University Hospital.
Lundereng ED, Nes AAG, Holmen H, Winger A, Thygesen H, Jøranson N, Borge CR, Dajani O, Mariussen KL, Steindal SA(2023) Health Care Professionals' Experiences and Perspectives on Using Telehealth for Home-based Palliative Care: Scoping Review J Med Internet Res, 25, e43429 DOI 10.2196/43429, PubMed 36989024
Sørensen Ø, Fjell AM, Walhovd KB(2023) Longitudinal Modeling of Age-Dependent Latent Traits with Generalized Additive Latent and Mixed Models Psychometrika(in press) DOI 10.1007/s11336-023-09910-z, PubMed 36976415
Hatlestad-Hall C, Bruña R, Liljeström M, Renvall H, Heuser K, Taubøll E, Maestú F, Haraldsen IH(2023) Reliable evaluation of functional connectivity and graph theory measures in source-level EEG: How many electrodes are enough? Clin Neurophysiol, 150, 1-16(in press) DOI 10.1016/j.clinph.2023.03.002, PubMed 36972647